Novel PATL2 variants cause female infertility with oocyte maturation defect
Journal of Assisted Reproduction and Genetics · 2024
DOI: 10.1007/s10815-024-03150-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Assisted Reproduction and Genetics, 2024. Verfasst von Hua-Ying Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Birth Defects Prevention and Control Technology Research Center, Medical Innovation Research Division of Chinese, PLA General Hospital, Beijing, 1008…. Hauptthemen laut MEDLINE: Exome Sequencing, Infertility, Female, Oocytes, Oogenesis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE: Oocyte maturation defect (OOMD) is a rare cause of in vitro fertilization failure characterized by the production of immature oocytes. Compound heterozygous or homozygous PATL2 mutations have been associated with oocyte arrest at the germinal vesicle (GV), metaphase I (MI), and metaphase II (MII) stages, as well as morphological changes. METHODS: In this study, we recruited three OOMD cases and conducted a comprehensive multiplatform laboratory investigation. RESULTS: Whole exome sequence (WES) revealed four diagnostic variants in PATL2, nonsense mutation c.709C > T (p.R237*) and frameshift mutation c.1486_1487delinsT (p.A496Sfs*4) were novel mutations that have not been reported previously. Furthermore, the pathogenicity of these variants was predicted using in silico analysis, which indicated detrimental effects. Molecular dynamic analysis suggested that the A496S variant disrupted the hydrophobic segment, leading to structural changes that affected the overall protein folding and stability. Additionally, biochemical and molecular experiments were conducted on cells transfected with wild-type (WT) or mutant PATL2 (p.R237* and p.A496Sfs*4) plasmid vectors. CONCLUSIONS: The results demonstrated that PATL2A496Sfs*4 and PATL2R237* had impacts on protein size and expression level. Interestingly, expression levels of specific genes involved in oocyte maturation and early embryonic development were found to be simultaneously deregulated. The findings in our study expand the variation spectrum of the PATL2 gene, provide solid evidence for counseling on future pregnancies in affected families, strongly support the application of in the diagnosis of OOMD, and contribute to the understanding of PATL2 function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Birth Defects Prevention and Control Technology Research Center, Medical Innovation Research Division of Chinese, PLA General Hospital, Beijing, 100853, China.
- Translational Medicine Research Center, Medical Innovation Research Division of Chinese, PLA General Hospital, Beijing, China.
- Shenzhen Hengsheng Hospital, Shenzhen, Guangdong, China.
- Jiaen Genetics Laboratory, Beijing Jiaen Hospital, Beijing, 100191, China.
- The Reproduction Medical Center, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518001, Guangdong, China. 13723470237@163.com.
- Jiaen Genetics Laboratory, Beijing Jiaen Hospital, Beijing, 100191, China. jiaenliu@jiaenhospital.com.
Zitieren
APA
Hu, H. Y., Zhang, G. H., Deng, W. F., Wei, T. Y., Feng, Z. K., Li, C. X., Li, S. J., Liu, J. E., & Tian, Y. P. (2024). Novel PATL2 variants cause female infertility with oocyte maturation defect. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-024-03150-5
Vancouver
Hu HY, Zhang GH, Deng WF, Wei TY, Feng ZK, Li CX, et al. Novel PATL2 variants cause female infertility with oocyte maturation defect. Journal of Assisted Reproduction and Genetics. 2024. doi:10.1007/s10815-024-03150-5
BibTeX
@article{Hu2024,
author = {Hu, Hua-Ying and Zhang, Ge-Han and Deng, Wei-Fen and Wei, Tian-Ying and Feng, Zhan-Ke and Li, Cun-Xi and Li, Song Jun and Liu, Jia-En and Tian, Ya-Ping},
title = {Novel PATL2 variants cause female infertility with oocyte maturation defect},
journal = {Journal of Assisted Reproduction and Genetics},
year = {2024},
doi = {10.1007/s10815-024-03150-5}
}
EUVIMED